Services
Discover
Homeschooling
Ask a Question
Log in
Sign up
Filters
Done
Question type:
Essay
Multiple Choice
Short Answer
True False
Matching
Topic
Nursing
Study Set
Applied Pharmacology
Quiz 14: Drugs for the Treatment of Cardiovascular Disease
Path 4
Access For Free
Share
All types
Filters
Study Flashcards
Practice Exam
Learn
Question 41
Multiple Choice
Angiotensin receptor blockers (ARBs) end with the suffix:
Question 42
Multiple Choice
Patients taking antihypertensive agents who have been supine for some time should be slowly raised from that position. They should dangle their legs over the side of the chair and wiggle them before rising to the standing position.
Question 43
Multiple Choice
Which of the following statements is true of ezetimibe?
Question 44
Multiple Choice
Severe hypotension and reflex tachycardia are caused by combination of sympathomimetics, such as epinephrine, with which antihypertensive agent class?
Question 45
Multiple Choice
Many _____ end in the suffix -pril.
Question 46
Multiple Choice
Which of the following statements is true concerning hyperlipidemia and cholesterol?
Question 47
Multiple Choice
Which agent is most likely to cause xerostomia?
Question 48
Multiple Choice
A serious lupus-like reaction is associated with which cardiovascular drug?
Question 49
Multiple Choice
When a physician finds out that his female patient wishes to start a family, he decides to change her cholesterol-lowering medication. He changes her medication from:
Question 50
Multiple Choice
All of the following effects are characteristic of channel-blocking agents except which one?
Question 51
Multiple Choice
Which of the following categories of antihypertensive agents end in the suffix -dipine?
Question 52
Multiple Choice
Treatment with all of the following agents is associated with development of gingival hypertrophy except which one?
Question 53
Multiple Choice
Which of the following categories of agents may be used to treat both hypertension and benign prostatic hypertrophy?
Question 54
Multiple Choice
The newest guidelines from the ACC/AHA recommend using HMG-coA reductase inhibitors (statins) as the drugs of first choice for treating patients with atherosclerotic cardiovascular disease based on: